In recent trading, DexCom Inc (DXCM) shares have surpassed the average analyst 12-month target price of $86.11, currently trading at $87.31. This movement prompts analysts to consider revising their price targets based on the company’s fundamental developments. There are 27 analyst targets contributing to this average, with predictions ranging from a low of $64.00 to a high of $112.00 and a standard deviation of $9.435.
Currently, the analyst ratings for DexCom show a strong bullish sentiment, with 24 strong buy ratings, 1 buy rating, 3 hold ratings, and only 1 strong sell rating. The average rating sits at 1.38, on a scale where 1 is a strong buy and 5 is a strong sell. This data indicates a consensus among analysts to reassess the stock’s potential as it approaches and exceeds the average target price.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
